Katya Kosheleva

Katya Kosheleva has a strong background in bioinformatics and scientific research. Katya is currently working as a Principal Scientist at Prime Medicine, Inc. In this role, they are leveraging their expertise to contribute to the company's research and development efforts.

Prior to their current position, Katya worked at Invitae, where they held multiple roles. Katya started as a Senior Bioinformatics Scientist and later became the Oncology Bioinformatics Lead. In these positions, they played a central role in the development and implementation of bioinformatics programs for comprehensive genomic profiling and RNA-Seq analysis. Katya provided technical guidance to team members, collaborated with cross-functional stakeholders, and contributed to program planning and resourcing.

Before joining Invitae, Katya worked as a Bioinformatics Scientist at Good Start Genetics, where they gained valuable experience in the field.

Earlier in their career, Katya held research positions at Harvard University, Insight Data Science, University of Chicago Center for Integrative Science, Argonne National Laboratory, and Harvard John A. Paulson School of Engineering and Applied Sciences. In these roles, they conducted various experiments, developed bioinformatics pipelines, and contributed to scientific advancements in diverse fields such as evolution, colloidal hydrodynamics, cellular morphology, and particle physics.

Overall, Katya Kosheleva's work experience showcases their strong technical skills, research capabilities, and multidisciplinary expertise in bioinformatics and scientific research.

Katya Kosheleva pursued their education with great dedication and achieved impressive milestones during their academic journey. Katya completed their Bachelor of Science with Honors and Bachelor of Arts with Honors degrees in Math and Physics at the University of Chicago from 2007 to 2011. Building upon this solid foundation, they went on to pursue a PhD at Harvard University, specializing in the field of Physics. Katya successfully completed their doctoral studies at Harvard from 2011 to 2017.